Correlation Between Maxigen Biotech and Posiflex Technology

Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and Posiflex Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and Posiflex Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maxigen Biotech and Posiflex Technology, you can compare the effects of market volatilities on Maxigen Biotech and Posiflex Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of Posiflex Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and Posiflex Technology.

Diversification Opportunities for Maxigen Biotech and Posiflex Technology

0.41

Correlation Coefficient

Maxigen Biotech  Posiflex Technology

Very weak diversification

The 3 months correlation between Maxigen and Posiflex is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and Posiflex Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Posiflex Technology and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with Posiflex Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Posiflex Technology has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and Posiflex Technology go up and down completely randomly.

Pair Corralation between Maxigen Biotech and Posiflex Technology

Assuming the 90 days trading horizon Maxigen Biotech is expected to generate 0.68 times more return on investment than Posiflex Technology. However, Maxigen Biotech is 1.47 times less risky than Posiflex Technology. It trades about 0.15 of its potential returns per unit of risk. Posiflex Technology is currently generating about -0.01 per unit of risk. If you would invest  4,480  in Maxigen Biotech on December 2, 2024 and sell it today you would earn a total of  790.00  from holding Maxigen Biotech or generate 17.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Maxigen Biotech  vs.  Posiflex Technology

Maxigen Biotech

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Posiflex Technology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Posiflex Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Posiflex Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Maxigen Biotech and Posiflex Technology

The main advantage of trading using opposite Maxigen Biotech and Posiflex Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, Posiflex Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Posiflex Technology will offset losses from the drop in Posiflex Technology's long position.

The idea behind Maxigen Biotech and Posiflex Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.